ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma

Currently, there is no reliable biomarker to clinically predict the prognosis of lung adenocarcinoma (ADC). The receptor-tyrosine-kinase like orphan receptor 1 (ROR1) is reported to be overexpressed and associated with poor prognosis in several tumors. This study aimed to examine the expression of R...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yu-Zhu, Ma, Rui, Zhou, Jian-Kang, Guo, Cheng-Lin, Wang, Yong-Sheng, Li, Zheng-Guang, Liu, Lun-Xu, Peng, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103212/
https://www.ncbi.nlm.nih.gov/pubmed/27830754
http://dx.doi.org/10.1038/srep36447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103212/
https://www.ncbi.nlm.nih.gov/pubmed/27830754
http://dx.doi.org/10.1038/srep36447

Ejemplares similares